Gene · 5600
Papers1,936
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,936
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Investigation of the therapeutic role of native plant compounds against colorectal cancer based on system biology and virtual screening. | Sci Rep | 2023 | 37454152 | PubTator, text mining | PubMed |
| Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer. | Int J Mol Sci | 2023 | 37446011 | PubTator, text mining | PubMed |
| p38γ MAPK Inflammatory and Metabolic Signaling in Physiology and Disease. | Cells | 2023 | 37443708 | PubTator, text mining | PubMed |
| Aortic dissection induced by vascular endothelial growth factor inhibitors. | Front Pharmacol | 2023 | 37426822 | PubTator, text mining | PubMed |
| The p38/MK2 Pathway Functions as Chk1-Backup Downstream of ATM/ATR in G2-Checkpoint Activation in Cells Exposed to Ionizing Radiation. | Cells | 2023 | 37408221 | PubTator, text mining | PubMed |
| Identifying Patients With Rapid Progression From Hormone-Sensitive to Castration-Resistant Prostate Cancer: A Retrospective Study. | Mol Cell Proteomics | 2023 | 37394064 | PubTator, text mining | PubMed |
| Cardiovascular disease biomarkers derived from circulating cell-free DNA methylation. | NAR Genom Bioinform | 2023 | 37388821 | PubTator, text mining | PubMed |
| β-Lapachone Exerts Anticancer Effects by Downregulating p53, Lys-Acetylated Proteins, TrkA, p38 MAPK, SOD1, Caspase-2, CD44 and NPM in Oxaliplatin-Resistant HCT116 Colorectal Cancer Cells. | Int J Mol Sci | 2023 | 37373014 | PubTator, text mining | PubMed |
| Insight into the Inter-Organ Crosstalk and Prognostic Role of Liver-Derived MicroRNAs in Metabolic Disease Progression. | Biomedicines | 2023 | 37371692 | PubTator, text mining | PubMed |
| MAPK11 (p38β) is a major determinant of cellular radiosensitivity by controlling ionizing radiation-associated senescence: An in vitro study. | Clin Transl Radiat Oncol | 2023 | 37346275 | PubTator, text mining | PubMed |
| SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication. | mBio | 2023 | 37345956 | PubTator, text mining | PubMed |
| Alzheimer's disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy? | Front Pharmacol | 2023 | 37332353 | PubTator, text mining | PubMed |
| Repressor Element-1 Binding Transcription Factor (REST) as a Possible Epigenetic Regulator of Neurodegeneration and MicroRNA-Based Therapeutic Strategies. | Mol Neurobiol | 2023 | 37326903 | PubTator, text mining | PubMed |
| Characterization of p38α autophosphorylation inhibitors that target the non-canonical activation pathway. | Nat Commun | 2023 | 37308482 | PubTator, text mining | PubMed |
| Minor intron splicing is critical for survival of lethal prostate cancer. | Mol Cell | 2023 | 37295433 | PubTator, text mining | PubMed |
| Synthesis, In Silico Studies, and In Vitro Anti-Inflammatory Activity of Novel Imidazole Derivatives Targeting p38 MAP Kinase. | ACS Omega | 2023 | 37251188 | PubTator, text mining | PubMed |
| P38 kinase in gastrointestinal cancers. | Cancer Gene Ther | 2023 | 37248432 | PubTator, text mining | PubMed |
| A Chemical Proteomics Approach to Discover Regulators of Innate Immune Signaling. | Viruses | 2023 | 37243198 | PubTator, text mining | PubMed |
| Analysis of the Prognostic and Immunological Role of HSPB1 in Pituitary Adenoma: A Potential Target for Therapy. | Medicina (Kaunas) | 2023 | 37241117 | PubTator, text mining | PubMed |
| Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients' Induced Pluripotent Stem-Cell-Derived Cardiomyocytes. | Int J Mol Sci | 2023 | 37240001 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5600/papers?page=7